Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Ovarian Neoplasms

Free Subscription 05.01.2026 1 Anticancer Drugs 1 BMC Cancer 1 Br J Cancer 1 Cancer Lett 2 Curr Opin Obstet Gynecol 3 Eur J Obstet Gynecol Reprod Biol 4 Int J Gynaecol Obstet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Drugs

1. OZBERK U, Esen SA, Sekmek S, Seven I, et al
   Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity.
   Anticancer Drugs. 2025 Dec 18. doi: 10.1097/CAD.0000000000001798.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. ZHAO L, Nie J, Wang J, Li D, et al
   FOXL2 + cancer-associated fibroblasts enhances epithelial ovarian cancer development via TGFbeta/Smad signaling.
   BMC Cancer. 2025 Dec 23. doi: 10.1186/s12885-025-15364.
   PubMed        
   
   

   
   Br J Cancer

3. DE SOUZA WAGNER PH, Matheus GTFU, Monteiro Ribeiro D, Figueroa Magalhaes MC, et al
   Breast cancer incidence and subtype patterns among BRCA-mutated ovarian cancer patients: a systematic review and meta-analysis.
   Br J Cancer. 2025 Dec 23. doi: 10.1038/s41416-025-03320.
   PubMed         Abstract available
   
   

   
   Cancer Lett

4. DONG K, Cai M, Jia X, Qu H, et al
   A novel phenomena: extrachromosomal DNA harboring highly amplified and overexpressed genes undergo intercellular transmission in ovarian cancer cells.
   Cancer Lett. 2025;639:218231.
   PubMed        
   
   

   
   Curr Opin Obstet Gynecol

5. THAKER SK, Silverstein J, Konecny GE, Bardia A, et al
   Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer.
   Curr Opin Obstet Gynecol. 2026;38:48-56.
   PubMed         Abstract available
   
   
6. RUSCITO I, Baisheva E, Taube ET, Ioana Braicu E, et al
   Mesothelin in solid tumors: biology, biomarker utility, and therapeutic targeting.
   Curr Opin Obstet Gynecol. 2026;38:34-40.
   PubMed         Abstract available
   
   

   
   Eur J Obstet Gynecol Reprod Biol

7. HALDER S, Meena J, Singhal S, Kumari R, et al
   Prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting response to neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer: a prospective study.
   Eur J Obstet Gynecol Reprod Biol. 2025;318:114901.
   PubMed         Abstract available
   
   
8. HONG M, Yang K, Ge H, Tang J, et al
   Prognostic factors for ovarian immature teratoma and significance of alpha-fetoprotein in recurrent cases.
   Eur J Obstet Gynecol Reprod Biol. 2025;317:114882.
   PubMed         Abstract available
   
   
9. LIANG J, Wu T, Feng X, Jin Y, et al
   Perspective on postoperative hormone replacement therapy and fertility preservation in Swyer syndrome with dysgerminoma: a case series and literature review.
   Eur J Obstet Gynecol Reprod Biol. 2026;317:114857.
   PubMed         Abstract available
   
   

   
   Int J Gynaecol Obstet

10. YONEMORI K, Yunokawa M, Matsumoto K, Takehara K, et al
    Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum-resistant ovarian cancer: Phase I expansion results.
    Int J Gynaecol Obstet. 2025 Dec 23. doi: 10.1002/ijgo.70676.
    PubMed         Abstract available
    
    
11. BRENNER S, King T, Roecker Z, Dansby K, et al
    Pediatric ovarian malignancies and outcomes in an urban tertiary care center.
    Int J Gynaecol Obstet. 2025 Jul 21. doi: 10.1002/ijgo.70400.
    PubMed         Abstract available
    
    
12. KARATAS E, Salman MC, Basaran D, Akgor U, et al
    Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
    PubMed         Abstract available
    
    
13. LI M, Xu S, Yang Q, Zheng Z, et al
    Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.